Minivelle (estradiol transdermal system)
Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.
The product was stored or shipped outside its labeled temperature range. Heat or freezing can degrade a drug without any visible change, so it may be weaker than labeled.
569 FDA drug recalls with this cause, newest first.
Vaccines, insulin, many injectables and some tablets must stay within a narrow temperature band from factory to pharmacy. A truck without working refrigeration, a freezer failure or a warehouse heatwave is enough: the product looks normal but may have lost potency or formed degradation products. FDA files these under 'CGMP deviations' or 'temperature abuse'; we track them separately because the question to ask - how was my medication stored? - is different from every other cause.
Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.
Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.
Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.
Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.
Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.
Temperature Abuse: One shipment was inadvertantly stored refrigerated rather than the labeled room temperature recommendation at McKesson Medical-Surgical Inc., one of the distributing wholesalers.
Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.
Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.
Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.
Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping
Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping
Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping
Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping
Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping
Failed Impurity/Degradation Specification; out-of-specification result for one individual unknown impurity at the 24-month room temperature stability test station.
Crystallization; visible crystals from the active ingredient formed due to extreme cold temperatures during shipping
Failed Moisture Limit; Out of Specification (OOS) results were obtained for moisture content during stability testing at the 12 month time point, controlled room temperature conditions.
Temperature abuse: Certain vials of Ifosfamide IV products were not refrigerated at certain Amerisource Bergen Drug Corp distribution centers.
Temperature abuse: Certain vials of Ifosfamide IV products were not refrigerated at certain Amerisource Bergen Drug Corp distribution centers.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.